Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 89 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 7338758

    Compositions and methods for the identification, assessment, prevention and therapy of human cancers

    The Board of Regents of the University of Texas System · Granted Mar 4, 2008 · Expires Feb 28, 2028

    granted

  2. US 7335662

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  3. US 7335679

    Wortmannin analogs and methods of using same

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 26, 2008 · Expires Feb 21, 2028

    granted

  4. US 7332159

    Method and composition for inhibiting reperfusion injury in the brain

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  5. US 7332469

    Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  6. US 7332321

    Viral fibers

    The Board of Regents of the University of Texas System · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  7. US 7332527

    Cross-linked ionic core micelles

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 19, 2008 · Expires Feb 14, 2028

    granted

  8. US 7329642

    β-2-glycoprotein is an inhibitor of angiogenesis

    The Board of Regents of the University of Texas System · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  9. US 7326713

    Substituted tricyclic compound as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted

  10. US 7326712

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Feb 5, 2008 · Expires Jan 31, 2028

    granted

  11. US 7323174

    Modulation of immune response and methods based thereon

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted

  12. US 7323166

    Lactic acid bacteria cultures that inhibit food-borne pathogens

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 29, 2008 · Expires Jan 24, 2028

    granted

  13. US 7319000

    Compositions and methods for eliciting immune or anti-infective responses

    The Board of Regents of the University of Texas System · Granted Jan 15, 2008 · Expires Jan 10, 2028

    granted

  14. US 7317020

    Isolation and structure of Cribrostatin 6

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA · Granted Jan 8, 2008 · Expires Jan 3, 2028

    granted

  15. US 7314911

    Prostate hyperplasia therapy

    The Board of Regents of the University of Texas System · Granted Jan 1, 2008 · Expires Dec 27, 2027

    granted

  16. US 7312202

    Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy

    The Board of Regents of the University of Texas System · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted

  17. US 7312226

    Substituted tricyclic compounds as protein kinase inhibitors

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Dec 25, 2007 · Expires Dec 20, 2027

    granted

  18. US 7309692

    Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1

    The Board of Regents of the University of Texas System · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  19. US 7309774

    Antiplasmin cleaving enzyme

    The Board of Regents of the University of Oklahoma · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  20. US 7309792

    Dimeric small molecule potentiators of apoptosis

    The Board of Regents of the University of Texas System · Granted Dec 18, 2007 · Expires Dec 13, 2027

    granted

  21. US 7306804

    HIV-specific T-cell induction

    The Board of Regents of the University of Texas System · Granted Dec 11, 2007 · Expires Dec 6, 2027

    granted

  22. US 7303887

    Mule: Mcl-1 ubiquitination ligase E3

    The Board of Regents of the University of Texas System · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

  23. US 7291336

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted

  24. US 7291348

    Compositions and methods for biodegradable microspheres as carriers of bioactive substances

    The Board of Regents of the University of Texas System · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.